Trial Profile
A Study to Evaluate the Efficacy and Tolerability of Dimethyl-fumarate in Patients With Multiple Sclerosis (MS) across Different Ethnic Groups (Caucasian, African and Hispanic-American)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Feb 2016
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 17 Feb 2016 New trial record